Status:
COMPLETED
Follow-up of a Cohort of Patients With Myasthenic Syndrome and COVID-19 Infection
Lead Sponsor:
University Hospital, Bordeaux
Conditions:
Myasthenia Gravis
Eligibility:
All Genders
1-99 years
Brief Summary
Coronavirus disease 2019 (COVID-19), declared by the World Health Organization (WHO) as a "public health emergency of international concern" (January 31, 2020), has posed a significant threat to globa...
Detailed Description
Coronavirus disease 2019 (COVID-19), declared by the World Health Organization (WHO) as a "public health emergency of international concern" (January 31, 2020), has posed a significant threat to globa...
Eligibility Criteria
Inclusion
- 1\. Child or adult patients, living or deceased, presenting or having presented a myasthenic syndrome and a COVID-19 infection 2. Myasthenic syndrome is established by:
- Either the presence of a specific antibody
- Either the presence of specific electrophysiological abnormalities
- Either an evocative symptomatology improved by a therapeutic test with an acetylcholinesterase inhibitor
- Either one or two pathogenic mutation (s) in a gene involved in congenital myasthenic syndromes (dominant or recessive disease).
- 3\. COVID-19 infection is established by
- Either a positive PCR test
- Or a specific chest scanner
- Either a positive serology
- Either a clinical syndrome of COVID-19, validated by a committee of experts. 4. Patients affiliated or beneficiaries of a social security scheme 5. For living patients: patients who have been informed of the study and have not exercised their right of opposition or parents or holders of parental authority who have been informed of the study and have not exercised their right opposition.
- For deceased patients: beneficiaries or parents / holders of parental authority having been informed of the study and not having exercised their right of objection.
Exclusion
- 1\. Persons placed under judicial protection
Key Trial Info
Start Date :
April 27 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 18 2020
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT04695379
Start Date
April 27 2020
End Date
June 18 2020
Last Update
October 6 2023
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU d'Angers
Angers, France, 49933
2
CHU de Bordeaux
Bordeaux, France, 33076
3
Hospices Civils de Lyon
Bron, France, 69677
4
APHP - Hopital Raymond Poincarré
Garches, France, 92380